In 2020, there were >1.4 million new prostate cancer cases and >370 000 related deaths reported globally.
Robot-assisted radical prostatectomy (RARP) is a surgical method used to eradicate localised prostate cancer.
However, erectile dysfunction (ED) and urinary incontinence (UI) are common side-effects.
This retrospective cohort study investigated erectile function, urinary continence, and oncological outcomes of nerve sparing (NS) in RARP.
